Trump Administration’s Medicaid and Medicare Decision:
- The Trump administration announced it would not extend coverage for weight loss drugs like Ozempic under Medicare Part D or Medicaid.
- This decision overturns prior plans to classify obesity as a disease eligible for coverage.
- An October 2024 Congressional Budget Office report estimated the cost of covering these medications would be $35 billion from 2026-2034.
- The Centers for Medicare and Medicaid Services acknowledged an exclusion for weight loss agents but allows exceptions if the drugs treat obesity.
Tags #International, #Security, #Politics
Want to read more about this ? One of the original source articles from a trusted news source (not legacy media) is here:
